Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
Bibliographic Data
Patients on risperidone and clozapine therapy may be at greater risk of developing metabolic syndrome than patients treated with aripiprazole. Statistically significant difference in concentration of TNF-α and TGF-β was in the group of patients treated with risperidone compared to healthy control group
Antipsychotic · Aripiprazole · Body mass index · Cholesterol · Clozapine · Insulin · Insulin resistance · Leptin · Lipid Profile · Metabolic syndrome · Obesity · Olanzapine · Positive and Negative Syndrome Scale · Psychiatry · Psychosis · Risperidone · Schizophrenia (object-oriented programming · Waist · Diabetes and associated disorders · Medicine · Schizophrenia research and treatment · Tryptophan and brain disorders · Endocrinology · Internal Medicine
The metabolic syndrome
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder
IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
| Citation velocity | historical |
|---|---|
| Highly cited | No |